Zemplar

Paricalcitol is a vitamin D analog prescribed to manage secondary hyperparathyroidism in chronic kidney disease. This oral medication supports calcium balance and bone health. It is available as soft capsules for convenient daily use. Always follow healthcare provider guidance when using paricalcitol.

Paricalcitol is used to treat secondary hyperparathyroidism in adults and pediatric patients with chronic kidney disease. It helps regulate parathyroid hormone levels to maintain calcium and phosphate balance. This medication is often prescribed when kidney function declines, reducing the risk of bone complications. It is taken orally and works by mimicking the effects of vitamin D.

Paricalcitol helps maintain normal calcium levels in the blood by reducing excess parathyroid hormone. It supports bone health by preventing mineral loss and improving mineralization. Some patients may experience mild gastrointestinal effects like nausea or constipation. These effects are generally temporary and should be discussed with a healthcare provider if they persist.

Store paricalcitol capsules at room temperature away from moisture and heat. Keep the medication in its original container and out of reach of children. Inform your healthcare provider about all medications and supplements you are taking before starting paricalcitol. Regular blood tests may be required to monitor calcium and parathyroid hormone levels during treatment.

Paricalcitol may interact with medications that affect calcium levels, such as calcium supplements or thiazide diuretics. Strong CYP3A inhibitors, like certain antifungals or antibiotics, can increase paricalcitol levels in the blood. Avoid consuming large amounts of foods high in calcium or vitamin D without medical advice. Alcohol and grapefruit products may also interact with paricalcitol.